
Sanofi To Invest $1.05 Bln For New Insulin Production Base In China
French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in Beijing, China, reports said. The move represents Sanofis single largest investment in China so far, where it has been present for more than 40 years. The investment will boost the manufacturing of...